Entrada (TRDA) CFO Kory Wentworth Sells 1,733 Shares

What Happened

• Kory James Wentworth, CFO of Entrada Therapeutics (TRDA), had 1,733 shares disposed on 2026-09-02 as a mandatory sell-to-cover to satisfy tax withholding obligations. The weighted-average sale price reported was $7.14, producing proceeds of roughly $12,380. This was a sale to cover taxes (not a discretionary open-market sale).

Key Details

• Transaction date: 2026-09-02; Form 4 filed 2026-09-03 (appears timely).
• Shares disposed: 1,733; reported weighted-average price: $7.14; total proceeds ≈ $12,380.
• Price range: shares were sold in multiple transactions at prices from $6.97 to $7.34 (footnote).
• Shares owned after the transaction: not specified in the provided filing details.
• Notable footnotes:
  • F1: Sale was automatic under a mandatory sell-to-cover provision to cover minimum statutory tax withholding — not a discretionary trade.
  • F2: Weighted-average price noted; reporting person will provide per-share price breakdown on request.

Context

• This is a routine sell-to-cover tied to tax withholding (common when options or awards vest/exercise). It should not be read as a voluntary insider sale signaling a view on the company. If you want the exact per-trade prices within the reported range, the filer has committed to provide that information upon request.